07:00 , Jun 25, 2007 |  BioCentury  |  Finance

Ebb & Flow

Stocks generally fall to account for dilution when companies propose follow-ons. But shares of Transgene (Euro-next:Transgene) rose both before and after the company's offering last week. Generalist investors from across the continent with little exposure...
00:08 , Jun 23, 2007 |  BC Extra  |  Financial News

TopoTarget raises $64.7 million

TopoTarget (CSE:TOPO) raised DKK360 million ($64.7 million) through the sale of 12 million shares at DKK30 in a public offering in Denmark and a private placement to institutional investors elsewhere except the U.S. TOPO proposed...
01:14 , Jun 21, 2007 |  BC Extra  |  Financial News

Amsterdam Molecular prices IPO

Amsterdam Molecular (Euronext:AMT) raised EUR 50 million ($66.9 million) through the sale of 5 million shares at EUR 10 in an IPO on Euronext Amsterdam's Eurolist and a private placement outside of the Netherlands and...
07:00 , Jun 11, 2007 |  BioCentury  |  Finance

Ebb & Flow

The Street had a mixed reaction to the pair of private companies that Amgen (AMGN) picked up last week. One of them seems to be a close fit with AMGN's existing products and sales strategy...
01:02 , Jun 7, 2007 |  BC Extra  |  Financial News

Amsterdam Molecular updates IPO plans

Amsterdam Molecular (Amsterdam, the Netherlands) said it plans to sell up to 5 million shares at EUR 8-EUR 10 in an IPO on Euronext Amsterdam's Eurolist and a private placement outside of the Netherlands and...
07:00 , May 28, 2007 |  BioCentury  |  Finance

Adding up Addex

Buysiders were clearly split on the pricing of the Addex IPO on the SWX Swiss Exchange last week. Despite being more than four times over-subscribed, the stock - which priced last Monday at CHF73 a...
01:05 , May 23, 2007 |  BC Extra  |  Financial News

Amsterdam Molecular planning IPO

Amsterdam Molecular (Amsterdam, the Netherlands) said it is planning an IPO on Euronext Amsterdam's Eurolist within the next few weeks. ABN AMRO Rothschild and Kempen are joint global coordinators and joint bookrunners. Amsterdam Molecular's lead...
02:18 , Nov 29, 2006 |  BC Extra  |  Financial News

TopoTarget raises $22.2 million

Cancer company TopoTarget (CSE:TOPO) raised DKK126.7 million ($22.2 million) in a placing of 4.2 million shares at DKK30.50. ABN AMRO Rothschild and Handelsbanken Capital Markets were the placement agents. TOPO's Savene dexrazoxane is approved in...
02:00 , Nov 28, 2006 |  BC Extra  |  Financial News

TopoTarget plans placing

Cancer company TopoTarget (CSE:TOPO) plans to sell up to 4.2 million shares in a placing to institutional investors. If sold in full at TOPO's Friday close of DKK32.60, TOPO would raise DKK135.40 ($23.8 million). ABN...
02:02 , Jan 28, 2006 |  BC Extra  |  Financial News

Genmab raises $119.5 million

Genmab (CSE:GEN) raised DKK735 million ($119.5 million) through a private placement of 5 million shares at DKK147, which was GEN's closing price on Thursday. Merrill Lynch; Alfred Berg; and ABN AMRO Rothschild managed the placement....